• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

YKL-40 as a new promising prognostic marker of severity in COVID infection.

作者信息

Schoneveld Lauranne, Ladang Aurélie, Henket Monique, Frix Anne-Noëlle, Cavalier Etienne, Guiot Julien

机构信息

Department of Clinical Chemistry, University of Liege, CHU de Liège, Domaine Universitaire du Sart-Tilman, B35, 4000, Liège, Belgium.

Department of Pneumology, CHU de Liège, Liège, Belgium.

出版信息

Crit Care. 2021 Feb 16;25(1):66. doi: 10.1186/s13054-020-03383-7.

DOI:10.1186/s13054-020-03383-7
PMID:33593373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7886185/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a5/7888077/3a2f4a46f2d2/13054_2020_3383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a5/7888077/3a2f4a46f2d2/13054_2020_3383_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/91a5/7888077/3a2f4a46f2d2/13054_2020_3383_Fig1_HTML.jpg

相似文献

1
YKL-40 as a new promising prognostic marker of severity in COVID infection.YKL-40作为新型且有前景的新冠病毒感染严重程度的预后标志物。
Crit Care. 2021 Feb 16;25(1):66. doi: 10.1186/s13054-020-03383-7.
2
Clinical Utility of YKL-40 in Polymyositis/dermatomyositis-associated Interstitial Lung Disease.YKL-40 在多发性肌炎/皮肌炎相关间质性肺疾病中的临床应用。
J Rheumatol. 2017 Sep;44(9):1394-1401. doi: 10.3899/jrheum.170373. Epub 2017 Jul 15.
3
YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.YKL-40、CCL18 和 SP-D 可预测社区获得性肺炎住院患者的死亡率。
Respirology. 2017 Apr;22(3):542-550. doi: 10.1111/resp.12924. Epub 2016 Oct 26.
4
YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis.血清 YKL-40（几丁质酶 3 样蛋白 1）在主动脉瓣狭窄中的水平。
Circ Heart Fail. 2020 Oct;13(10):e006643. doi: 10.1161/CIRCHEARTFAILURE.119.006643. Epub 2020 Sep 23.
5
Serum chitotriosidase and YKL-40 in acute pancreatitis: Reliability as prognostic marker for disease severity and correlation with inflammatory markers.血清几丁质酶 3 样蛋白 1 和 YKL-40 在急性胰腺炎中的作用：作为疾病严重程度的预后标志物的可靠性及其与炎症标志物的相关性。
Turk J Med Sci. 2021 Dec 13;51(6):3038-3046. doi: 10.3906/sag-2106-59.
6
YKL-40 levels are associated with disease severity and prognosis of viral pneumonia, but not available in bacterial pneumonia in children.YKL-40 水平与病毒性肺炎的疾病严重程度和预后相关，但在儿童细菌性肺炎中不可用。
BMC Pediatr. 2018 Dec 4;18(1):381. doi: 10.1186/s12887-018-1345-y.
7
Serum YKL-40 level is associated with severity of interstitial lung disease and poor prognosis in dermatomyositis with anti-MDA5 antibody.血清 YKL-40 水平与抗 MDA5 抗体相关性皮肌炎患者间质性肺病严重程度及预后不良相关。
Clin Rheumatol. 2019 Jun;38(6):1655-1663. doi: 10.1007/s10067-019-04457-w. Epub 2019 Feb 9.
8
YKL-40 levels increase with declining ankle-brachial index and are associated with long-term cardiovascular mortality in peripheral arterial disease patients.YKL-40 水平随着踝臂指数的降低而升高，与外周动脉疾病患者的长期心血管死亡率相关。
Atherosclerosis. 2018 Jul;274:152-156. doi: 10.1016/j.atherosclerosis.2018.05.006. Epub 2018 May 9.
9
Elevated serum YKL-40 correlates with clinical characteristics in patients with polymyositis or dermatomyositis.血清 YKL-40 水平升高与多发性肌炎或皮肌炎患者的临床特征相关。
Ann Clin Biochem. 2019 Jan;56(1):95-99. doi: 10.1177/0004563218786979. Epub 2018 Jul 18.
10
YKL-40 as marker of severe lung disease in cystic fibrosis patients.YKL-40作为囊性纤维化患者严重肺部疾病的标志物。
J Cyst Fibros. 2016 Sep;15(5):583-6. doi: 10.1016/j.jcf.2015.12.020. Epub 2016 Jan 8.

引用本文的文献

1
Elevated KLF2 and YKL-40 with reduced vitamin A as predictive biomarkers for severity and prognosis in neonatal respiratory distress syndrome.KLF2和YKL-40升高且维生素A降低作为新生儿呼吸窘迫综合征严重程度和预后的预测生物标志物。
Am J Transl Res. 2025 May 15;17(5):3424-3434. doi: 10.62347/ZNNV1969. eCollection 2025.
2
Elucidating SARS-CoV-2 neurotropism: a comprehensive Mendelian randomization study on cerebrospinal fluid biomarkers and their relevance to COVID-19 neurological manifestations.阐明严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）的嗜神经性：一项关于脑脊液生物标志物及其与冠状病毒病2019（COVID-19）神经表现相关性的综合孟德尔随机化研究。
Virol J. 2025 Apr 28;22(1):123. doi: 10.1186/s12985-025-02754-2.
3

本文引用的文献

1
Diagnostic and Prognostic Biomarkers for Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype.具有进行性表型的慢性纤维化间质性肺疾病的诊断和预后生物标志物
Chest. 2020 Aug;158(2):646-659. doi: 10.1016/j.chest.2020.03.037. Epub 2020 Apr 5.
2
Biomarkers in systemic sclerosis-associated interstitial lung disease: review of the literature.系统性硬皮病相关间质性肺疾病的生物标志物：文献综述。
Rheumatology (Oxford). 2019 Sep 1;58(9):1534-1546. doi: 10.1093/rheumatology/kez230.
3
Blood Biomarkers in Idiopathic Pulmonary Fibrosis.
Early Fever in Allogeneic Stem Cell Transplantation: Are Presepsin and YKL-40 Valuable Diagnostic Tools?
异基因造血干细胞移植中的早期发热：可溶性髓系细胞触发受体-1和YKL-40是有价值的诊断工具吗？
J Clin Med. 2024 Oct 8;13(19):5991. doi: 10.3390/jcm13195991.
4
Evaluation of the relationship between YKL-40 level and clinical severity in patients with Crimean-Congo hemorrhagic fever.评估克里米亚-刚果出血热患者 YKL-40 水平与临床严重程度的关系。
Pathog Glob Health. 2024 Sep;118(6):492-498. doi: 10.1080/20477724.2024.2392225. Epub 2024 Aug 14.
5
Research advances in serum chitinase-3-like protein 1 in liver fibrosis.血清壳多糖酶-3样蛋白1在肝纤维化中的研究进展
Front Med (Lausanne). 2024 Jun 19;11:1372434. doi: 10.3389/fmed.2024.1372434. eCollection 2024.
6
Potential marker subset of blood-circulating cytokines on hematopoietic progenitor-to-Th1 pathway in COVID-19.新冠病毒感染中造血祖细胞向Th1途径的血液中循环细胞因子的潜在标志物亚群
Front Med (Lausanne). 2024 Feb 27;11:1319980. doi: 10.3389/fmed.2024.1319980. eCollection 2024.
7
CCL18, CHI3L1, ANG2, IL-6 systemic levels are associated with the extent of lung damage and radiomic features in SARS-CoV-2 infection.CCL18、CHI3L1、ANG2、IL-6 等系统水平与 SARS-CoV-2 感染中肺损伤的程度和放射组学特征有关。
Inflamm Res. 2024 Apr;73(4):515-530. doi: 10.1007/s00011-024-01852-1. Epub 2024 Feb 3.
8
Kidney Damage in Long COVID: Studies in Experimental Mice.新冠长期症状中的肾脏损伤：对实验小鼠的研究
Biology (Basel). 2023 Jul 30;12(8):1070. doi: 10.3390/biology12081070.
9
Biomarker Profiles Associated with COVID-19 Severity and Mortality.与新冠病毒疾病严重程度和死亡率相关的生物标志物特征
Curr Issues Mol Biol. 2023 Mar 1;45(3):1998-2012. doi: 10.3390/cimb45030128.
10
Serum YKL-40 Levels in Patients with Asthma or COPD: A Pilot Study.哮喘或 COPD 患者的血清 YKL-40 水平：一项初步研究。
Medicina (Kaunas). 2023 Feb 16;59(2):383. doi: 10.3390/medicina59020383.
特发性肺纤维化中的血液生物标志物
Lung. 2017 Jun;195(3):273-280. doi: 10.1007/s00408-017-9993-5. Epub 2017 Mar 28.
4
Serum and BALF YKL-40 levels are predictors of survival in idiopathic pulmonary fibrosis.血清和 BALF YKL-40 水平是特发性肺纤维化患者生存的预测因子。
Respir Med. 2011 Jan;105(1):106-13. doi: 10.1016/j.rmed.2010.09.012.
5
YKL-40 is elevated in patients with chronic obstructive pulmonary disease and activates alveolar macrophages.YKL-40在慢性阻塞性肺疾病患者中升高，并激活肺泡巨噬细胞。
J Immunol. 2008 Oct 1;181(7):5167-73. doi: 10.4049/jimmunol.181.7.5167.
6
High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.系统性硬化症患者血清中高水平的YKL-40与肺部受累有关。
Scand J Rheumatol. 2005 Jul-Aug;34(4):293-7. doi: 10.1080/03009740510018598.